[go: up one dir, main page]

CN115894207A - Synthesis method of 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid - Google Patents

Synthesis method of 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid Download PDF

Info

Publication number
CN115894207A
CN115894207A CN202211573194.5A CN202211573194A CN115894207A CN 115894207 A CN115894207 A CN 115894207A CN 202211573194 A CN202211573194 A CN 202211573194A CN 115894207 A CN115894207 A CN 115894207A
Authority
CN
China
Prior art keywords
adamantane
acid
hydroxy
oxoacetic acid
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202211573194.5A
Other languages
Chinese (zh)
Other versions
CN115894207B (en
Inventor
黄陈赛
吴�荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Kanglirui Biotechnology Co ltd
Original Assignee
Nanjing Kanglirui Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Kanglirui Biotechnology Co ltd filed Critical Nanjing Kanglirui Biotechnology Co ltd
Priority to CN202211573194.5A priority Critical patent/CN115894207B/en
Publication of CN115894207A publication Critical patent/CN115894207A/en
Application granted granted Critical
Publication of CN115894207B publication Critical patent/CN115894207B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种2‑(3‑羟基‑1‑金刚烷)‑2‑氧代乙酸的合成方法,具体的包括以下步骤:步骤1:溴代金刚烷和金属镁反应生成格氏试剂;步骤2:格氏试剂和乙腈反应,再在酸性水溶液中水解得到1‑金刚烷甲酮;步骤3:1‑金刚烷甲酮用高锰酸钾在碱性水溶液中氧化得到金刚烷酮酸;步骤4:金刚烷酮酸在浓硝酸和浓硫酸的混合溶剂中反应后水解得到2‑(3‑羟基‑1‑金刚烷)‑2‑氧代乙酸。本发明的一种2‑(3‑羟基‑1‑金刚烷)‑2‑氧代乙酸的合成方法步骤较少,收率高,原料简单易得,合成方法操作简单。The invention discloses a synthesis method of 2-(3-hydroxyl-1-adamantane)-2-oxoacetic acid, specifically comprising the following steps: Step 1: reacting bromoadamantane and metal magnesium to generate Grignard reagent; Step 2: Grignard reagent reacts with acetonitrile, and then hydrolyzes in acidic aqueous solution to obtain 1-adamantanyl ketone; Step 3: 1-adamantanyl ketone is oxidized with potassium permanganate in alkaline aqueous solution to obtain adamantanonic acid; Step 4: adamantanone acid is reacted in a mixed solvent of concentrated nitric acid and concentrated sulfuric acid and then hydrolyzed to obtain 2-(3-hydroxyl-1-adamantane)-2-oxoacetic acid. The synthesis method of 2-(3-hydroxyl-1-adamantane)-2-oxoacetic acid of the present invention has fewer steps, high yield, simple and easy-to-obtain raw materials, and simple operation of the synthesis method.

Description

一种2-(3-羟基-1-金刚烷)-2-氧代乙酸的合成方法A kind of synthetic method of 2-(3-hydroxyl-1-adamantane)-2-oxoacetic acid

技术领域technical field

本发明涉及医药中间体合成技术领域,具体涉及一种2-(3-羟基-1-金刚烷)-2-氧代乙酸的合成方法。The invention relates to the technical field of synthesis of pharmaceutical intermediates, in particular to a synthesis method of 2-(3-hydroxy-1-adamantane)-2-oxoacetic acid.

背景技术Background technique

沙格列汀(saxagliptin),商品名Onglyza,化学名为(1S,3S,5S)-2-[(2S)-2-氨基-2-(3-羟基三环[3.3.1.13,7]癸-1-基)乙酰基]-2-氮杂双环[3.1.0]-己烷-3-腈,由Bristol-Myers Squibb公司与AstraZeneca公司联合开发,2009年7月经FDA批准上市。沙克列汀是一种高选择性、可逆性的竞争性二肽基肽酶Ⅳ(DPP-Ⅳ)抑制剂,耐受性好且不引起肥胖,临床用于治疗Ⅱ型糖尿病。Saxagliptin, trade name Onglyza, chemical name (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]decane -1-yl)acetyl]-2-azabicyclo[3.1.0]-hexane-3-carbonitrile, jointly developed by Bristol-Myers Squibb and AstraZeneca, approved by FDA in July 2009. Saxagliptin is a highly selective and reversible competitive dipeptidyl peptidase Ⅳ (DPP-Ⅳ) inhibitor, which is well tolerated and does not cause obesity. It is clinically used for the treatment of type Ⅱ diabetes.

2-(3-羟基-1-金刚烷基)-2-氧代乙酸是合成沙格列汀的重要中间体,CAS登记号为:709031-28-7,其结构式为:2-(3-Hydroxy-1-adamantyl)-2-oxoacetic acid is an important intermediate for the synthesis of saxagliptin, the CAS registration number is: 709031-28-7, and its structural formula is:

Figure BDA0003988351320000011
Figure BDA0003988351320000011

Letters in Organic Chemistry,2012,9(5),347-350将制备得到的金刚烷甲酰氯与丙二酸二乙酯的钠盐反应后,水解脱羧得乙酰金刚烷,再经高锰酸钾氧化、羟基化得到2-(3-羟基-1-金刚烷基)-2-氧代乙酸;Letters in Organic Chemistry, 2012, 9(5), 347-350 reacts the prepared adamantanecarbonyl chloride with the sodium salt of diethyl malonate, hydrolyzes and decarboxylates to obtain acetyladamantane, and then oxidizes it with potassium permanganate , hydroxylation to obtain 2-(3-hydroxyl-1-adamantyl)-2-oxoacetic acid;

Figure BDA0003988351320000012
Figure BDA0003988351320000012

其中,合成乙酰金刚烷需要三步反应,路线较长,产率较低。Among them, the synthesis of acetyladamantane requires three steps of reaction, the route is longer and the yield is lower.

发明内容Contents of the invention

1.所要解决的技术问题:1. Technical problems to be solved:

针对上述技术问题,本发明提供一种2-(3-羟基-1-金刚烷)-2-氧代乙酸的合成方法。In view of the above technical problems, the present invention provides a synthetic method of 2-(3-hydroxy-1-adamantane)-2-oxoacetic acid.

2.技术方案:2. Technical solution:

一种2-(3-羟基-1-金刚烷)-2-氧代乙酸的合成方法,所述合成方法的路线如下:A kind of synthetic method of 2-(3-hydroxyl-1-adamantane)-2-oxoacetic acid, the route of described synthetic method is as follows:

Figure BDA0003988351320000021
Figure BDA0003988351320000021

具体的包括以下步骤:Specifically, the following steps are included:

步骤1:溴代金刚烷和金属镁反应生成格氏试剂;Step 1: bromoadamantane reacts with metal magnesium to generate Grignard reagent;

步骤2:格氏试剂和乙腈反应,再在酸性水溶液中水解得到1-金刚烷甲酮;Step 2: Grignard reagent reacts with acetonitrile, and then hydrolyzes in acidic aqueous solution to obtain 1-adamantanyl ketone;

步骤3:1-金刚烷甲酮用高锰酸钾在碱性水溶液中氧化得到金刚烷酮酸;Step 3: 1-adamantanone ketone is oxidized with potassium permanganate in alkaline aqueous solution to obtain adamantanonic acid;

步骤4:金刚烷酮酸在浓硝酸和浓硫酸的混合溶剂中反应后水解得到2-(3-羟基-1-金刚烷)-2-氧代乙酸。Step 4: reacting adamantanone acid in a mixed solvent of concentrated nitric acid and concentrated sulfuric acid and then hydrolyzing it to obtain 2-(3-hydroxy-1-adamantane)-2-oxoacetic acid.

进一步地,步骤1的反应溶剂为四氢呋喃或者乙醚。Further, the reaction solvent in step 1 is tetrahydrofuran or diethyl ether.

进一步地,步骤1的溴代金刚烷和金属镁的摩尔比为1:1.1-1.3。Further, the molar ratio of bromoadamantane and metal magnesium in step 1 is 1:1.1-1.3.

进一步地,步骤2的乙腈和步骤1的溴代金刚烷的摩尔比为1.5-3:1。Further, the molar ratio of the acetonitrile in step 2 to the bromoadamantane in step 1 is 1.5-3:1.

进一步地,步骤2的酸性水溶液为稀盐酸。Further, the acidic aqueous solution in step 2 is dilute hydrochloric acid.

进一步地,步骤3中还可以加入叔丁醇作为助溶剂。Further, in step 3, tert-butanol can also be added as a cosolvent.

进一步地,步骤3的碱性水溶液为氢氧化钠或者氢氧化钾的水溶液。Further, the alkaline aqueous solution in step 3 is an aqueous solution of sodium hydroxide or potassium hydroxide.

进一步地,步骤4的浓硝酸和浓硫酸的体积比为1:10-15。Further, the volume ratio of concentrated nitric acid and concentrated sulfuric acid in step 4 is 1:10-15.

3.有益效果:3. Beneficial effects:

本发明的一种2-(3-羟基-1-金刚烷)-2-氧代乙酸的合成方法步骤较少,收率高,原料简单易得,合成方法操作简单。The synthesis method of 2-(3-hydroxyl-1-adamantane)-2-oxoacetic acid of the present invention has fewer steps, high yield, simple and easy-to-obtain raw materials, and simple operation of the synthesis method.

具体实施方式Detailed ways

下面对本发明进行具体的说明。The present invention will be specifically described below.

实施例1Example 1

一种2-(3-羟基-1-金刚烷)-2-氧代乙酸的合成方法,包括以下步骤:A kind of synthetic method of 2-(3-hydroxyl-1-adamantane)-2-oxoacetic acid, comprises the following steps:

Figure BDA0003988351320000031
Figure BDA0003988351320000031

步骤1:将Mg(1.3g,53.5mmol)加入干燥的四氢呋喃(10mL)中,氮气保护下,按照常规格氏试剂制备引发后,剧烈搅拌,升温至40℃,将溴代金刚烷(10g,46.5mmol)溶解在干燥的四氢呋喃(100mL),滴加至该溶液中,期间形成弱回流,滴加完毕后,回流反应1h,冷至室温,形成格氏试剂四氢呋喃溶液。Step 1: Add Mg (1.3g, 53.5mmol) into dry tetrahydrofuran (10mL), under the protection of nitrogen, prepare according to the conventional Grignard reagent, stir vigorously, heat up to 40°C, and bromoadamantane (10g, 46.5mmol) was dissolved in dry tetrahydrofuran (100mL), and added dropwise to the solution, during which a weak reflux was formed. After the dropwise addition, the solution was refluxed for 1h and cooled to room temperature to form a Grignard reagent tetrahydrofuran solution.

Figure BDA0003988351320000032
Figure BDA0003988351320000032

步骤2:干燥的乙腈(3.8g,92.6mmol)用四氢呋喃40ml稀释,冷却到-68℃,将步骤1制备的格氏试剂慢慢滴加到该溶液中,滴加时间控制在2h,滴加结束后继续在此温度下反应4h,慢慢滴加2mol/L稀盐酸至pH至7以下,继续搅拌1h。减压浓缩除去部分四氢呋喃,用乙酸乙酯50ml萃取三次,合并有机相,有机相用饱和食盐水洗涤,用无水硫酸钠干燥后,过滤,浓缩,粗品用二氯甲烷:正己烷(1:10)结晶纯化,得到1-金刚烷甲酮(7.2g,40.4mmol),步骤1-2两步收率为86.9%。Step 2: Dried acetonitrile (3.8g, 92.6mmol) was diluted with 40ml of tetrahydrofuran, cooled to -68°C, and the Grignard reagent prepared in step 1 was slowly added dropwise to the solution, and the dropping time was controlled at 2h. After the end, continue to react at this temperature for 4 hours, slowly add 2 mol/L dilute hydrochloric acid dropwise until the pH is below 7, and continue stirring for 1 hour. Concentrate under reduced pressure to remove part of tetrahydrofuran, extract three times with 50 ml of ethyl acetate, combine the organic phases, wash the organic phase with saturated brine, dry with anhydrous sodium sulfate, filter, concentrate, and dichloromethane: n-hexane (1: 10) Purification by crystallization to obtain 1-adamantanyl ketone (7.2 g, 40.4 mmol), the yield of step 1-2 is 86.9%.

Figure BDA0003988351320000033
Figure BDA0003988351320000033

步骤3:在1-金刚烷甲酮(5.0g,28mmol)中加入100ml 2%KOH溶液,20ml叔丁醇,加热至40℃,1小时内分批加入高锰酸钾(8g,50.6mmol),保持40℃反应5个小时,加入20mL10%亚硫酸钠溶液淬灭反应。趁热抽滤,滤饼用15ml热水洗涤。滤液冷却至室温,用浓盐酸调到pH=1,乙酸乙酯萃取三次,合并有机层用饱和食盐水洗涤,无水硫酸钠干燥,减压浓缩至油状物,用乙酸乙酯∶正己烷(1∶1)结晶得金刚烷酮酸的白色固体5.3g,收率90.74%。Step 3: Add 100ml 2% KOH solution, 20ml tert-butanol to 1-adamantanyl ketone (5.0g, 28mmol), heat to 40°C, add potassium permanganate (8g, 50.6mmol) in batches within 1 hour , kept at 40° C. for 5 hours, and added 20 mL of 10% sodium sulfite solution to quench the reaction. Suction filtration while hot, and the filter cake was washed with 15ml of hot water. The filtrate was cooled to room temperature, adjusted to pH = 1 with concentrated hydrochloric acid, extracted three times with ethyl acetate, the combined organic layers were washed with saturated brine, dried over anhydrous sodium sulfate, concentrated under reduced pressure to an oil, and washed with ethyl acetate: n-hexane ( 1:1) crystallization to obtain 5.3 g of white solid of adamantanonic acid, yield 90.74%.

Figure BDA0003988351320000041
Figure BDA0003988351320000041

步骤4:在0℃~5℃下,将金刚烷酮酸(5g,24mmol)分批加入65%硝酸(2.5mL)和95%硫酸(27mL)的混合物中,保持温度不高于25℃。然后室温反应3小时,反应液变为深黄色,将此反应混合物倒入冰水,用乙酸乙酯萃取有机层(50mL×3)。合并有机层并用饱和食盐水洗,浓缩得到粗品,粗品用乙酸乙酯:正己烷(1:3)重结晶,得到2-(3-羟基-1-金刚烷)-2-氧代乙酸(4.0g,17.8mmol),收率74.3%。Step 4: Add adamantanonic acid (5 g, 24 mmol) in batches to a mixture of 65% nitric acid (2.5 mL) and 95% sulfuric acid (27 mL) at 0°C to 5°C, keeping the temperature not higher than 25°C. Then reacted at room temperature for 3 hours, and the reaction solution turned dark yellow. The reaction mixture was poured into ice water, and the organic layer was extracted with ethyl acetate (50 mL×3). The organic layers were combined and washed with saturated brine, and concentrated to obtain a crude product, which was recrystallized from ethyl acetate:n-hexane (1:3) to obtain 2-(3-hydroxy-1-adamantane)-2-oxoacetic acid (4.0g , 17.8mmol), yield 74.3%.

虽然本发明已以较佳实施例公开如上,但它们并不是用来限定本发明的,任何熟习此技艺者,在不脱离本发明之精神和范围内,自当可作各种变化或润饰,因此本发明的保护范围应当以本申请的权利要求保护范围所界定的为准。Although the present invention has been disclosed as above with preferred embodiments, they are not intended to limit the present invention. Any skilled person can make various changes or modifications without departing from the spirit and scope of the present invention. Therefore, the protection scope of the present invention should be defined by the protection scope of the claims of the present application.

Claims (8)

1. A synthetic method of 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid is characterized in that the route of the synthetic method is as follows:
Figure FDA0003988351310000011
the method specifically comprises the following steps:
step 1: reacting bromoadamantane and magnesium metal to generate a Grignard reagent;
step 2: reacting the Grignard reagent with acetonitrile, and hydrolyzing in an acidic aqueous solution to obtain 1-adamantane ketone;
step 5363, oxidizing the 3:1-adamantane ketone in an alkaline aqueous solution by using potassium permanganate to obtain adamantane keto acid;
and 4, step 4: reacting adamantane acid in a mixed solvent of concentrated nitric acid and concentrated sulfuric acid, and hydrolyzing to obtain 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid.
2. The method for synthesizing 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid according to claim 1, wherein the reaction solvent in step 1 is tetrahydrofuran or diethyl ether.
3. The synthesis method of 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid according to claim 1, wherein the molar ratio of bromoadamantane and magnesium metal in step 1 is 1.1-1.3.
4. The method for synthesizing 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid according to claim 2 or 3, wherein the molar ratio of acetonitrile in step 2 to bromoadamantane in step 1 is 1.5-3:1.
5. The method for synthesizing 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid according to claim 4, characterized in that the acidic aqueous solution in step 2 is diluted hydrochloric acid.
6. The method for synthesizing 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid according to claim 5, wherein tert-butanol is further added as a cosolvent in step 3.
7. The method for synthesizing 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid according to claim 6, wherein the alkaline aqueous solution in step 3 is an aqueous solution of sodium hydroxide or potassium hydroxide.
8. The method for synthesizing 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid according to claim 7, wherein the volume ratio of the concentrated nitric acid and the concentrated sulfuric acid in the step 4 is 1.
CN202211573194.5A 2022-12-08 2022-12-08 A method for synthesizing 2-(3-hydroxy-1-adamantane)-2-oxoacetic acid Active CN115894207B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211573194.5A CN115894207B (en) 2022-12-08 2022-12-08 A method for synthesizing 2-(3-hydroxy-1-adamantane)-2-oxoacetic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211573194.5A CN115894207B (en) 2022-12-08 2022-12-08 A method for synthesizing 2-(3-hydroxy-1-adamantane)-2-oxoacetic acid

Publications (2)

Publication Number Publication Date
CN115894207A true CN115894207A (en) 2023-04-04
CN115894207B CN115894207B (en) 2025-05-02

Family

ID=86470955

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211573194.5A Active CN115894207B (en) 2022-12-08 2022-12-08 A method for synthesizing 2-(3-hydroxy-1-adamantane)-2-oxoacetic acid

Country Status (1)

Country Link
CN (1) CN115894207B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012028721A1 (en) * 2010-09-03 2012-03-08 Sandoz Ag PROCESS FOR THE REDUCTIVE AMINATION OF α-KETO CARBOXYLIC ACIDS
CN102807487A (en) * 2012-09-03 2012-12-05 方正 Synthetic method of onglyza intermediate
CN114621068A (en) * 2022-03-31 2022-06-14 沧州那瑞化学科技有限公司 Preparation method of 3-hydroxy-1-adamantane methyl ketone and method for synthesizing saxagliptin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012028721A1 (en) * 2010-09-03 2012-03-08 Sandoz Ag PROCESS FOR THE REDUCTIVE AMINATION OF α-KETO CARBOXYLIC ACIDS
CN102807487A (en) * 2012-09-03 2012-12-05 方正 Synthetic method of onglyza intermediate
CN114621068A (en) * 2022-03-31 2022-06-14 沧州那瑞化学科技有限公司 Preparation method of 3-hydroxy-1-adamantane methyl ketone and method for synthesizing saxagliptin

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANMIN WANG, ET AL.: "A Convenient Method for the Synthesis of (S)-N-boc-3-hydroxyadamantyl- glycine: A Key Intermediate of Saxagliptin", 《LETTERS IN ORGANIC CHEMISTRY》, vol. 11, 31 December 2014 (2014-12-31), pages 627 - 631 *
DAVID GRASSI, ET AL.: "Formation of chiral fluoroalkyl products through copper-free enantioselective allylic alkylation catalyzed by an NHC ligand", 《CHEM. COMMUN.》, vol. 48, 3 October 2012 (2012-10-03), pages 11404 - 11406 *
YURCHENKO, A. G. AND FEDORENKO, T. V.: "Reaction of adamantanoid organomagnesium compounds with carbonyl compounds", 《ZHURNAL ORGANICHESKOI KHIMII》, vol. 23, no. 5, 31 December 1987 (1987-12-31), pages 970 - 976 *
冯悦 等: "星点设计-效应面优化法优化2-(3-羟基-1-金刚烷基)-2-乙醛酸的合成工艺", 《化学研究与应用》, vol. 25, no. 2, 28 February 2013 (2013-02-28), pages 194 - 199 *
王安民 等: "N-叔丁氧羰基-3-羟基-1-金刚烷基甘氨酸的合成", 《化学研究与应用》, vol. 26, no. 4, 30 April 2014 (2014-04-30), pages 527 - 531 *

Also Published As

Publication number Publication date
CN115894207B (en) 2025-05-02

Similar Documents

Publication Publication Date Title
CN104761456B (en) Preparation method of 3-amino-1-adamantanol
CN104262359A (en) Synthetic method of salbactam acid
WO2023060811A1 (en) Fluralaner intermediate and method for preparing fluralaner thereby
CN112898307A (en) Ketorolac impurity C and preparation method and application thereof
CN105732444A (en) Synthesis method of belinostat
CN102267961B (en) Method for preparing ethyl (3R,4R,5S)-4,5-epoxy-3-(1-ethyl-propoxy)-1-cyclohexene-1-formate
JPS6222740A (en) Isolation of p-hydroxybenzaldehyde
CN115894207A (en) Synthesis method of 2- (3-hydroxy-1-adamantane) -2-oxoacetic acid
CN108440409B (en) Green and efficient preparation method of rebamipide
JP4450881B2 (en) Process for producing 5,5'-bi-1H-tetrazole salt
CN102485722B (en) Aliskiren, its intermediates and medicinal salt, as well as preparation method thereof
WO2005110962A1 (en) Process for producing adipic acid
CN111440079B (en) A kind of synthetic method of DL-threo-p-chlorophenylserine
US12448360B2 (en) Synthesis method for preparing SGLT inhibitor intermediate
CN115124452A (en) Preparation method of 2- (4-amino-2-ethoxyphenyl) isoindole-1, 3-dione
CN114044770B (en) Method for removing pigment impurities of sartan compounds in water phase
CN108137485A (en) The preparation method of benzoic acid amide compound
CN115417794B (en) Preparation method of saxagliptin intermediate
CN117510567B (en) A method for preparing high-purity alfaxalone
CN112661688B (en) Synthetic method of non-steroidal anti-inflammatory drug tolmetin
CN109384701A (en) It is a kind of to be used to prepare compound and the preparation method and application thereof of the Sha Ku than song
CN116924919A (en) Synthesis method of N- (2-methoxyethyl) ethylamine
CN117126101A (en) An efficient preparation method of proline structure hydrochloride intermediate
CN118851972A (en) A method for industrial preparation of antiviral ketoamide derivative intermediates
CN111620892A (en) Method for synthesizing sulbactam acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant